Παραπομπή σε μορφή APA (7η εκδ.)

Chakravarthy, U., Harding, S., Rogers, C., Downes, S., Lotery, A., Wordsworth, S., & Reeves, B. (2012). Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration.

Παραπομπή σε μορφή Chicago (17η εκδ.)

Chakravarthy, U., S. Harding, C. Rogers, S. Downes, A. Lotery, S. Wordsworth, και B. Reeves. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.

Παραπομπή σε μορφή MLA (9th εκδ.)

Chakravarthy, U., et al. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.